Form 4: Xtant Medical CFO Sells Shares for Tax Obligations

Xtant Medical Holdings, Inc. CFO Scott C Neils disposed of 8,084 common shares to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Scott C Neils, the Chief Financial Officer and Assistant Secretary of Xtant Medical Holdings, Inc. (XTNT), reported a transaction on January 15, 2026.
• The transaction involved the disposition of 8,084 shares of Xtant Medical Holdings, Inc. common stock.
• These shares were withheld by the Issuer to satisfy tax withholding obligations upon the vesting and settlement of restricted stock unit awards.
• The price per share for the disposed securities was $0.65.
• Following this transaction, Mr. Neils beneficially owns 843,381 shares of common stock.
• This beneficial ownership includes 498,914 shares issuable upon vesting and settlement of restricted stock unit (RSU) and DSU awards under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan.
• It also includes 62,974 shares issuable upon vesting and settlement of RSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.
• All RSU and DSU awards are conditioned upon Mr. Neils remaining an employee of Xtant through their respective vesting dates.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes upon the vesting of restricted stock units. This is a non-discretionary event and does not indicate positive or negative sentiment regarding the company's performance or future prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction filing (Form 4) detailing the disposition of shares by a corporate officer to cover tax obligations upon the vesting of restricted stock units. Such transactions are common across all industries and do not typically reflect a change in management's sentiment towards the company's prospects, but rather a standard administrative event related to equity compensation.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in insider sentiment or company fundamentals.

Key Dates

Keywords

XTNT, Xtant Medical Holdings, Form 4, insider transaction, stock sale, CFO, restricted stock units, tax withholding, equity incentive plan